Search by Drug Name or NDC
NDC 64980-0133-01 DIPYRIDAMOLE 25 mg/1 Details
DIPYRIDAMOLE 25 mg/1
DIPYRIDAMOLE is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rising Pharmaceuticals, Inc.. The primary component is DIPYRIDAMOLE.
MedlinePlus Drug Summary
Dipyridamole is used with other drugs to reduce the risk of blood clots after heart valve replacement. It works by preventing excessive blood clotting.
Related Packages: 64980-0133-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Dipyridamole
Product Information
| NDC | 64980-0133 |
|---|---|
| Product ID | 64980-133_f0e7ea64-b873-0fc4-e053-2a95a90ae18d |
| Associated GPIs | 85150030000310 |
| GCN Sequence Number | 041698 |
| GCN Sequence Number Description | dipyridamole TABLET 25 MG ORAL |
| HIC3 | M9P |
| HIC3 Description | PLATELET AGGREGATION INHIBITORS |
| GCN | 53141 |
| HICL Sequence Number | 000168 |
| HICL Sequence Number Description | DIPYRIDAMOLE |
| Brand/Generic | Generic |
| Proprietary Name | DIPYRIDAMOLE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | DIPYRIDAMOLE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | DIPYRIDAMOLE |
| Labeler Name | Rising Pharmaceuticals, Inc. |
| Pharmaceutical Class | Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA040733 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 64980-0133-01 (64980013301)
| NDC Package Code | 64980-133-01 |
|---|---|
| Billing NDC | 64980013301 |
| Package | 100 TABLET, FILM COATED in 1 BOTTLE (64980-133-01) |
| Marketing Start Date | 2007-08-05 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.06294 |
| Pricing Unit | EA |
| Effective Date | 2021-10-20 |
| NDC Description | DIPYRIDAMOLE 25 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2022-10-12 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis